TargED Biopharmaceuticals B.V.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From TargED Biopharmaceuticals B.V.
Sharing his thoughts on the European funding landscape, the importance of software, and sustainable investments, INKEF Capital’s Thijs Cohen Tervaert talks to In Vivo about his investment priorities.
The Dutch firm expects the financing to advance its novel asset Microlyse into a potentially pivotal study for a rare blood disorder.
- Drug Delivery
- Large Molecule